The vital signs monitoring devices market size has grown rapidly in recent years. It will grow from $9.93 billion in 2024 to $11.07 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth during the historical period was driven by an increasing number of chronic conditions, a globally aging population, heightened awareness about early diagnosis and health surveillance, greater acceptance of remote patient monitoring, and a surge in demand for home-based healthcare services.
The vital signs monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $16.83 billion in 2029 at a compound annual growth rate (CAGR) of 11%. Factors contributing to this growth include increased global healthcare spending, a growing number of cardiovascular cases, the rising prominence of telehealth services, higher occurrences of respiratory ailments, and a shift in patient preference toward less invasive monitoring solutions. Key trends anticipated during the forecast period include innovation in wearable medical technology, the emergence of portable and compact monitoring devices, increased integration of IoT in healthcare, the utilization of cloud platforms for data storage and analytics, and the wider adoption of devices capable of monitoring multiple vital parameters.
The growing prevalence of cardiovascular diseases is expected to drive the expansion of the vital signs monitoring devices market in the coming years. These diseases encompass a range of disorders affecting the heart and blood vessels, often resulting in heart attacks, strokes, and other circulatory issues. The rise in cardiovascular conditions is primarily due to increasing obesity rates, which heighten the risk of hypertension, diabetes, and high cholesterol - key contributors to heart-related complications. Vital signs monitoring devices play a crucial role in the management, diagnosis, and prevention of cardiovascular diseases. These tools aid in detecting early warning signs, monitoring disease progression, and guiding treatment decisions. For example, in January 2025, the American Heart Association reported that the United States recorded 941,652 deaths related to cardiovascular disease in 2022, up by more than 10,000 from the 931,578 deaths in 2021. As a result, the growing incidence of cardiovascular diseases is set to propel the demand for vital signs monitoring devices.
Companies in the vital signs monitoring devices market are increasingly developing advanced technologies, such as early warning scoring tools integrated with monitoring devices, to minimize human error. These systems continuously monitor patient vital signs to detect early signs of clinical deterioration and prompt timely medical intervention. For instance, in July 2024, Huntleigh, a US-based medical equipment manufacturer, introduced the SC500 Series vital signs monitor. This high-performance device supports both spot checks and extended observations, bridging the gap between basic and multi-parameter monitors. It includes integrated early warning scoring tools and three-level alarms, making it ideal for long-term COVID-19 monitoring. The monitor features an 8-inch color display and can operate on battery or mains power. It provides comprehensive monitoring for adults, children, and newborns, including non-invasive blood pressure, pulse rate, pulse oximetry, 3-lead ECG, and an optional wireless tympanic temperature sensor. Additionally, the SC500 enhances workflow efficiency through standard connectivity options and compatibility with Smartsigns Central View monitoring software for centralized data management.
In August 2022, Medtronic Plc, an Ireland-based medical device company, partnered with BioIntelliSense to distribute multi-parameter wearable devices in the United States for continuous remote patient monitoring. This partnership gives Medtronic exclusive distribution rights for the BioButton wearable across U.S. hospitals and for up to 30 days post-discharge. The collaboration enables Medtronic to offer ongoing, medical-grade vital signs monitoring for patients both during hospital stays and after they return home. BioIntelliSense is a U.S.-based company that manufactures vital sign monitoring devices.
Major players in the vital signs monitoring devices market are Medtronic Plc, Koninklijke Philips NV, GE Healthcare Technologies Inc., Baxter International Inc., Omron Healthcare, Mindray Ltd., Masimo Corp., Nihon Kohden Corp., Lepu Medical Technology Co. Ltd., Contec Medical Systems Co. Ltd., iRhythm Technologies Inc., A&D Company Ltd., Spacelabs Healthcare Inc., Schiller AG, Edan Instruments Inc., Shenzhen Comen Medical Instruments Co. Ltd., Nonin Medical Inc., Recorders & Medicare Systems P Ltd., BPL Medical Technologies, SunTech Medical Inc., Rossmax International Ltd., Allengers Medical Systems Ltd., Huntleigh Healthcare LLC, BioBeat Technologies, Ababil Healthcare.
North America was the largest region in the vital signs monitoring devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in vital signs monitoring devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the vital signs monitoring devicesmarket report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Vital signs monitoring devices are essential medical instruments used to continuously or periodically measure and track key physiological parameters that indicate the body’s critical functions. These devices are integral to modern healthcare as they help monitor physiological patterns and assist healthcare professionals in making timely and informed clinical decisions.
The primary categories of vital signs monitoring devices include blood pressure monitors, pulse oximeters, temperature monitoring devices, and glucose monitors. Pulse oximeters are compact devices that assess the oxygen saturation level in a person's blood, typically by attaching to a finger or earlobe. These devices are available in both standalone and portable forms and are utilized across various settings such as hospitals, clinics, home care, ambulatory centers, emergency departments, and more.
The vital signs monitoring devices market research report is one of a series of new reports that provides vital signs monitoring devices market statistics, including vital signs monitoring devices industry global market size, regional shares, competitors with a vital signs monitoring devices market share, detailed vital signs monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the vital signs monitoring devices industry. This vital signs monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vital signs monitoring devices market consists of sales of respiratory rate monitors, wearable health trackers, multi-parameter patient monitors, and neonatal vital signs monitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The vital signs monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $16.83 billion in 2029 at a compound annual growth rate (CAGR) of 11%. Factors contributing to this growth include increased global healthcare spending, a growing number of cardiovascular cases, the rising prominence of telehealth services, higher occurrences of respiratory ailments, and a shift in patient preference toward less invasive monitoring solutions. Key trends anticipated during the forecast period include innovation in wearable medical technology, the emergence of portable and compact monitoring devices, increased integration of IoT in healthcare, the utilization of cloud platforms for data storage and analytics, and the wider adoption of devices capable of monitoring multiple vital parameters.
The growing prevalence of cardiovascular diseases is expected to drive the expansion of the vital signs monitoring devices market in the coming years. These diseases encompass a range of disorders affecting the heart and blood vessels, often resulting in heart attacks, strokes, and other circulatory issues. The rise in cardiovascular conditions is primarily due to increasing obesity rates, which heighten the risk of hypertension, diabetes, and high cholesterol - key contributors to heart-related complications. Vital signs monitoring devices play a crucial role in the management, diagnosis, and prevention of cardiovascular diseases. These tools aid in detecting early warning signs, monitoring disease progression, and guiding treatment decisions. For example, in January 2025, the American Heart Association reported that the United States recorded 941,652 deaths related to cardiovascular disease in 2022, up by more than 10,000 from the 931,578 deaths in 2021. As a result, the growing incidence of cardiovascular diseases is set to propel the demand for vital signs monitoring devices.
Companies in the vital signs monitoring devices market are increasingly developing advanced technologies, such as early warning scoring tools integrated with monitoring devices, to minimize human error. These systems continuously monitor patient vital signs to detect early signs of clinical deterioration and prompt timely medical intervention. For instance, in July 2024, Huntleigh, a US-based medical equipment manufacturer, introduced the SC500 Series vital signs monitor. This high-performance device supports both spot checks and extended observations, bridging the gap between basic and multi-parameter monitors. It includes integrated early warning scoring tools and three-level alarms, making it ideal for long-term COVID-19 monitoring. The monitor features an 8-inch color display and can operate on battery or mains power. It provides comprehensive monitoring for adults, children, and newborns, including non-invasive blood pressure, pulse rate, pulse oximetry, 3-lead ECG, and an optional wireless tympanic temperature sensor. Additionally, the SC500 enhances workflow efficiency through standard connectivity options and compatibility with Smartsigns Central View monitoring software for centralized data management.
In August 2022, Medtronic Plc, an Ireland-based medical device company, partnered with BioIntelliSense to distribute multi-parameter wearable devices in the United States for continuous remote patient monitoring. This partnership gives Medtronic exclusive distribution rights for the BioButton wearable across U.S. hospitals and for up to 30 days post-discharge. The collaboration enables Medtronic to offer ongoing, medical-grade vital signs monitoring for patients both during hospital stays and after they return home. BioIntelliSense is a U.S.-based company that manufactures vital sign monitoring devices.
Major players in the vital signs monitoring devices market are Medtronic Plc, Koninklijke Philips NV, GE Healthcare Technologies Inc., Baxter International Inc., Omron Healthcare, Mindray Ltd., Masimo Corp., Nihon Kohden Corp., Lepu Medical Technology Co. Ltd., Contec Medical Systems Co. Ltd., iRhythm Technologies Inc., A&D Company Ltd., Spacelabs Healthcare Inc., Schiller AG, Edan Instruments Inc., Shenzhen Comen Medical Instruments Co. Ltd., Nonin Medical Inc., Recorders & Medicare Systems P Ltd., BPL Medical Technologies, SunTech Medical Inc., Rossmax International Ltd., Allengers Medical Systems Ltd., Huntleigh Healthcare LLC, BioBeat Technologies, Ababil Healthcare.
North America was the largest region in the vital signs monitoring devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in vital signs monitoring devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the vital signs monitoring devicesmarket report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Vital signs monitoring devices are essential medical instruments used to continuously or periodically measure and track key physiological parameters that indicate the body’s critical functions. These devices are integral to modern healthcare as they help monitor physiological patterns and assist healthcare professionals in making timely and informed clinical decisions.
The primary categories of vital signs monitoring devices include blood pressure monitors, pulse oximeters, temperature monitoring devices, and glucose monitors. Pulse oximeters are compact devices that assess the oxygen saturation level in a person's blood, typically by attaching to a finger or earlobe. These devices are available in both standalone and portable forms and are utilized across various settings such as hospitals, clinics, home care, ambulatory centers, emergency departments, and more.
The vital signs monitoring devices market research report is one of a series of new reports that provides vital signs monitoring devices market statistics, including vital signs monitoring devices industry global market size, regional shares, competitors with a vital signs monitoring devices market share, detailed vital signs monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the vital signs monitoring devices industry. This vital signs monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vital signs monitoring devices market consists of sales of respiratory rate monitors, wearable health trackers, multi-parameter patient monitors, and neonatal vital signs monitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Vital Signs Monitoring Devices Market Characteristics3. Vital Signs Monitoring Devices Market Trends And Strategies4. Vital Signs Monitoring Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market32. Global Vital Signs Monitoring Devices Market Competitive Benchmarking And Dashboard33. Key Mergers And Acquisitions In The Vital Signs Monitoring Devices Market34. Recent Developments In The Vital Signs Monitoring Devices Market
5. Global Vital Signs Monitoring Devices Growth Analysis And Strategic Analysis Framework
6. Vital Signs Monitoring Devices Market Segmentation
7. Vital Signs Monitoring Devices Market Regional And Country Analysis
8. Asia-Pacific Vital Signs Monitoring Devices Market
9. China Vital Signs Monitoring Devices Market
10. India Vital Signs Monitoring Devices Market
11. Japan Vital Signs Monitoring Devices Market
12. Australia Vital Signs Monitoring Devices Market
13. Indonesia Vital Signs Monitoring Devices Market
14. South Korea Vital Signs Monitoring Devices Market
15. Western Europe Vital Signs Monitoring Devices Market
16. UK Vital Signs Monitoring Devices Market
17. Germany Vital Signs Monitoring Devices Market
18. France Vital Signs Monitoring Devices Market
19. Italy Vital Signs Monitoring Devices Market
20. Spain Vital Signs Monitoring Devices Market
21. Eastern Europe Vital Signs Monitoring Devices Market
22. Russia Vital Signs Monitoring Devices Market
23. North America Vital Signs Monitoring Devices Market
24. USA Vital Signs Monitoring Devices Market
25. Canada Vital Signs Monitoring Devices Market
26. South America Vital Signs Monitoring Devices Market
27. Brazil Vital Signs Monitoring Devices Market
28. Middle East Vital Signs Monitoring Devices Market
29. Africa Vital Signs Monitoring Devices Market
30. Vital Signs Monitoring Devices Market Competitive Landscape And Company Profiles
31. Vital Signs Monitoring Devices Market Other Major And Innovative Companies
35. Vital Signs Monitoring Devices Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Vital Signs Monitoring Devices Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on vital signs monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for vital signs monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vital signs monitoring devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Pulse Oximeters; Blood Pressure Monitors; Temperature Monitoring Devices; Glucose Monitoring Devices2) By Mount Type: Standalone; Portable
3) By End-Use: Hospitals; Physician’s Office; Home Healthcare; Ambulatory Centers; Emergency Care Centers; Other End-Uses
Subsegments:
1) By Pulse Oximeters: Fingertip Pulse Oximeters; Handheld Pulse Oximeters; Tabletop Or Benchtop Pulse Oximeters; Wrist-Worn Pulse Oximeters; Pediatric Pulse Oximeters2) By Blood Pressure Monitors: Automated Or Digital Blood Pressure Monitors; Manual Blood Pressure Monitors; Ambulatory Blood Pressure Monitors; Wrist Blood Pressure Monitors; Upper Arm Blood Pressure Monitors
3) By Temperature Monitoring Devices: Digital Thermometers; Infrared Thermometers; Mercury Thermometers; Wearable Continuous Temperature Monitoring Devices; Smart Thermometers
4) By Glucose Monitoring Devices: Self-Monitoring Blood Glucose (SMBG) Devices; Continuous Glucose Monitoring (CGM) Systems
Key Companies Profiled: Medtronic Plc; Koninklijke Philips NV; GE Healthcare Technologies Inc.; Baxter International Inc.; Omron Healthcare
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Medtronic Plc
- Koninklijke Philips NV
- GE Healthcare Technologies Inc.
- Baxter International Inc.
- Omron Healthcare
- Mindray Ltd.
- Masimo Corp.
- Nihon Kohden Corp.
- Lepu Medical Technology Co. Ltd.
- Contec Medical Systems Co. Ltd.
- iRhythm Technologies Inc.
- A&D Company Ltd.
- Spacelabs Healthcare Inc.
- Schiller AG
- Edan Instruments Inc.
- Shenzhen Comen Medical Instruments Co. Ltd.
- Nonin Medical Inc.
- Recorders & Medicare Systems P Ltd.
- BPL Medical Technologies
- SunTech Medical Inc.
- Rossmax International Ltd.
- Allengers Medical Systems Ltd.
- Huntleigh Healthcare LLC
- BioBeat Technologies
- Ababil Healthcare
